Zobrazeno 1 - 10
of 5 340
pro vyhledávání: '"Microvascular complications"'
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 4191-4198 (2024)
Yuchen Tang,1 PingPing Zhang,2 Li Li,1 Jialin Li1 1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, People’s Republic of China; 2Ningbo Center for Healthy Lifestyle Research,
Externí odkaz:
https://doaj.org/article/89b43c9e1c0c49969802a4dd01f51a8e
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 5, Pp 732-747 (2024)
Background This study investigated the prognostic importance of the hemoglobin glycation index (HGI) for macrovascular and microvascular outcomes, mortality, and hypoglycemia occurrence in a type 2 diabetes cohort and compared it to glycated hemoglob
Externí odkaz:
https://doaj.org/article/fb98ab2a1a58421dbb07de9d98c6367e
Autor:
Alanood A. Howsawi, Manal M. Alem
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Glycemic variability (GV), independently of glycemic control, has emerged as a prognostic marker in patients with type 2 diabetes mellitus (DM). In this study, we assessed the prognostic value of long-term GV for predicting major adverse car
Externí odkaz:
https://doaj.org/article/80c02a40306a4b9abbe1bc5962cc004a
Autor:
Andrey F. Verbovoy, Yulia A. Dolgikh
Publikováno v:
Consilium Medicum, Vol 26, Iss 8, Pp 516-521 (2024)
Diabetes mellitus (DM) is a non-communicable epidemic. The number of people with this pathology is growing every year. DM leads to a decrease in quality and life expectancy due to vascular complications. However, the manifestations of diabetes are va
Externí odkaz:
https://doaj.org/article/17260100c0ff459ea94539e569da6113
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Patients with type 2 diabetes mellitus (T2D) have an increased risk of vascular complications. Despite the rise in the prevalence of T2D and its complications throughout the globe, there is a paucity of data regarding the prevalen
Externí odkaz:
https://doaj.org/article/a0c87b31229e46149869278a4d788a9d
Autor:
Naser A. Alsharairi
Publikováno v:
Pediatric Reports, Vol 16, Iss 3, Pp 763-778 (2024)
Type 1 diabetes mellitus (T1DM) is regarded as the most chronic autoimmune disease affecting children and adolescents that results from a destruction of pancreatic β-cell and leads to insulin insufficiency and persistent hyperglycemia (HG). Children
Externí odkaz:
https://doaj.org/article/22ed16d3012644a7a95704ea85e0bda5
Autor:
Noha G. Amin, A. Abdel Rahim, Kamel Rohoma, Reham A.Abo Elwafa, Hossam M. F. Dabees, Shimaa Elrahmany
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-9 (2024)
Abstract Background Dysregulation of the mechanistic target of rapamycin (mTOR) has been related to several metabolic conditions, notably obesity and type 2 diabetes (T2DM). This study aimed to evaluate the role of mTOR in patients with T2DM, and its
Externí odkaz:
https://doaj.org/article/c97203dbce89488787e80b03d3069ce3
Autor:
Caroline Christine Pincela da Costa, Leandro do Prado Assunção, Kamilla de Faria Santos, Laura da Silva, Rodrigo da Silva Santos, Angela Adamski da Silva Reis
Publikováno v:
Journal of Molecular Pathology, Vol 5, Iss 3, Pp 335-359 (2024)
Diabetic Nephropathy (DN) stands as a primary cause of end-stage renal disease and its etiology remains unclear. Thus, this study aims to construct a genetic panel with potential biomarkers linked to the inflammatory pathway of DN associated with the
Externí odkaz:
https://doaj.org/article/eb611b33009d47458ca6125538c9c9c4
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Anaemia is a global public health issue that impacts individuals of all ages in both developed and developing countries. Anaemia is common in patients with diabetes mellitus; however, it is often undiagnosed and untreated. The mai
Externí odkaz:
https://doaj.org/article/1dc8b094df1e4130bb69b8fc75ad441e
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background The purpose of this review was to examine if dipeptidyl peptidase-4 inhibitor (DPP4i) use affects the risk of diabetic retinopathy (DR). Methods Cohort studies published up to 20th July 2023 in the databases of PubMed, CENTRAL, Em
Externí odkaz:
https://doaj.org/article/2a33df47d779479e904dd61f1ae40a78